SVRA — Savara Inc. | XLV Holdings | StockAdder

(SVRA)

Savara Inc.

Live chart and latest SVRA stock news.

Sector ETF → XLV Health Care Select

Chart powered byTradingView— professional charts for every trader.Try it free →

SVRA News

Savara brings new rare lung disease data to 3 ATS presentations

Apr 14, 2026 Yahoo Finance

What Does Wall Street Think About Savara Inc. (SVRA)?

Oct 30, 2025 MarketBeat

Savara Inc. (NASDAQ:SVRA) Receives Consensus Rating of "Moderate Buy" from Brokerages

Mar 27, 2026 Business Wire

Savara Announces Pricing of $130.0 Million Public Offering of Common Stock and Pre-funded Warrants

Oct 29, 2025 Seeking Alpha

Savara Stock: A High-Risk Opportunity (NASDAQ:SVRA)

Nov 16, 2025 Investing.com

Citizens reiterates Savara stock rating on likely FDA approval

Feb 23, 2026 Stock Titan

Savara Inc. (NASDAQ: SVRA) proxy: MOLBREEVI FDA date, equity and vote items

Apr 10, 2026 StocksToTrade

Savara Stock: Will It Continue to Rise?

Nov 28, 2025 timothysykes.com

Savara Stock Surges Amid Positive Financial Developments and Raised Price Target

Nov 30, 2025 Yahoo Finance

Savara Inc. (SVRA) Upgraded to Buy After FDA CMC Breakthrough

Aug 23, 2025 Seeking Alpha

Savara: Back On Track With Upcoming APAP BLA Filing (NASDAQ:SVRA)

Oct 9, 2025 StocksToTrade

Savara Inc. Sees Price Target Raised Amid Promising Drug Developments

Nov 29, 2025 Stock Titan

Rare lung disease drug enters accelerated U.K. review for Q4 decision

Apr 7, 2026 Yahoo Finance

Savara Insiders Added US$535.6k Of Stock To Their Holdings

Feb 9, 2026 StocksToTrade

Savara Inc’s Stock Boosted by Strategic Financial Moves and Developments